Leak-Free adapter aims to keep ventilator air in and germs out during lung scopes
NCT ID NCT06310577
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to test a new device called a leak-free bronchoscope adapter. The goal was to see if it could reduce air leaking from the ventilator and limit the spread of aerosols into the operating room during bronchoscopy in intubated patients. The trial was withdrawn before enrolling any participants, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- leak-free bronchoscope adapter
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Expected to start
-
Jan 2024
An estimate. Start dates often move.
- Expected to finish
-
Nov 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Participants who will be undergoing elective intubation for either a surgical or bronchoscopic procedure (diagnostic or therapeutic) 2. Both males and females 3. Adults 18 years and older Exclusion Criteria: 1. Significant protocol deviation 2. Significant non-compliance with protocol or study requirements 3. An adverse event which requires discontinuation which results in the inability to continue to comply with study procedures. 4. Consent is withdrawn.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pulmonary disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NorthShore University HealthSystem
Chicago, Illinois, 60201, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an old malaria drug help fight severe COVID-19?
- Massive rural health study aims to uncover heart and lung disease risks
- 500 asthma patients enrolled in landmark biologic registry
- Breathing machine tweak may help oxygen during lung surgery
- Lung image & tissue bank aims to speed up new diagnostic tools
- Breath and blood tests could spot lung cancer early